PathoQuest

France · 52 Employees
PathoQuest helps biopharmaceutical developers and manufacturers get their therapies to market with our leading expertise in GMP NGS-based biosafety testing and characterization services. As innovator companies continue to bring exciting novel therapies to market, there is a critical need for alternative biosafety and characterization strategies. This is especially the case for life-changing cell and gene therapies, as well as novel viral vaccines. Classical testing approaches, such as cell based assays, are often challenging to implement due to high volume requirements, as well as compatibility issues. Biosafety testing and characterization are key regulatory requirements for the release of biologic therapies. Therefore, alternative methods which can address these issues are of intense interest. There is also a drive from across industry and regulators to reduce, and eventually eliminate the use of animal models used in biosafety testing. The genomic approach of Next Generation Sequencing (NGS) can solve many of the challenges that are faced by developers and manufacturers, such as lower volume requirements and incompatibility with cell-based assays From our origins within the Institut Pasteur, PathoQuest is leading the way in expertise for the provision of GMP NGS based biosafety testing. Our expertise is underlined with over 20 peer reviewed publications on NGS applications in biosafety testing; as well as active participation in industry groups such as PDA, ADVTIG, CAACB and EFPIA. PathoQuest are committed to bringing this game-changing genomic approach to biopharmaceutical developers and manufacturers. PathoQuest has a global footprint, with operations in Europe (Paris) and North America (Wayne, PA); and have provided NGS biosafety testing services to over 100 of the top biopharmaceutical companies globally. Why not get in touch to see how we can help you with your biosafety testing strategy?

概述

国家 France
成立时间 2011
总部 11 rue Watt, Paris, Île-de-France, FR, 75013
电话号码 +33 1 70 82 17 90
网站 http://www.pathoquest.com
LinkedIn http://www.linkedin.com/company/pathoquest
Twitter https://twitter.com/Pathoquest
Facebook
员工数 52
行业 research,
简介 PathoQuest helps biopharmaceutical developers and manufacturers get their therapies to market with our leading expertise in GMP NGS-based biosafety testing and characterization services. As innovator companies continue to bring exciting novel therapies to market, there is a critical need for alternative biosafety and characterization strategies. This is especially the case for life-changing cell and gene therapies, as well as novel viral vaccines. Classical testing approaches, such as cell based assays, are often challenging to implement due to high volume requirements, as well as compatibility issues. Biosafety testing and characterization are key regulatory requirements for the release of biologic therapies. Therefore, alternative methods which can address these issues are of intense interest. There is also a drive from across industry and regulators to reduce, and eventually eliminate the use of animal models used in biosafety testing. The genomic approach of Next Generation Sequencing (NGS) can solve many of the challenges that are faced by developers and manufacturers, such as lower volume requirements and incompatibility with cell-based assays From our origins within the Institut Pasteur, PathoQuest is leading the way in expertise for the provision of GMP NGS based biosafety testing. Our expertise is underlined with over 20 peer reviewed publications on NGS applications in biosafety testing; as well as active participation in industry groups such as PDA, ADVTIG, CAACB and EFPIA. PathoQuest are committed to bringing this game-changing genomic approach to biopharmaceutical developers and manufacturers. PathoQuest has a global footprint, with operations in Europe (Paris) and North America (Wayne, PA); and have provided NGS biosafety testing services to over 100 of the top biopharmaceutical companies globally. Why not get in touch to see how we can help you with your biosafety testing strategy?

技术

Amazon AWS

Hosting

Apache

Load Balancers

Google Font API

Fonts

Google Maps

Other

Google Tag Manager

Tag Management

Google translate API

Widgets

Google translate widget

Widgets

Mobile Friendly

Other

OpenSSL

SSL Certificates

Outlook

Email Providers

Route 53

Domain Name Services

Vimeo

Online Video Platforms

WordPress.org

CMS

常见问题

PathoQuest 在哪里?

PathoQuest 的总部位于 11 rue Watt, Paris, Île-de-France, FR, 75013

PathoQuest 的电话号码是多少?

PathoQuest 的电话号码是 +33 1 70 82 17 90

PathoQuest 的官方网站是什么?

PathoQuest 的公司官方网站是 http://www.pathoquest.com

PathoQuest 是做什么的?

PathoQuest 的业务有哪些?

PathoQuest 的年收入是多少?

PathoQuest 的收入是 10000000美元

PathoQuest 有多少员工?

PathoQuest 有 52 名员工

PathoQuest 属于哪个行业?

PathoQuest 从事以下行业: research

PathoQuest 使用什么技术?

PathoQuest 使用的一些流行技术包括: Amazon AWS,Apache,Google Font API,Google Maps,Google Tag Manager,Google translate API,Google translate widget,Mobile Friendly,OpenSSL,Outlook,Route 53,Vimeo,WordPress.org

如何联系 PathoQuest?

PathoQuest 联系信息: 电话号码:+33 1 70 82 17 90, 网站:http://www.pathoquest.com, 邮箱:mat***@***.com

PathoQuest 的社交媒体链接是什么?

PathoQuest 领英:http://www.linkedin.com/company/pathoquest,fackbook:,twitte:https://twitter.com/Pathoquest

PathoQuest 是一家上市公司吗?

不是

PathoQuest 的最后一轮融资是什么时候?

PathoQuest在2021-11-01T00:00:00.000+00:00结束了最后一轮融资,金额达11.6M$。

谁投资 PathoQuest?

PathoQuest 有 4 家投资者,包括 SHS Gesellschaft für Beteiligungsmanagement mbH, Turenne Groupe, Kurma Partners, Verve ventures, Eurazeo, Aurinvest, Charles River Laboratories、Norgine Ventures, Kurma Partners, Idinvest, Charles River, investiere、Idinvest Partners, Aurinvest, Kurma Life Science Partners、。

管理层

Sandrine Rousseau

Head of Bioinformatics

Adrien Josso

Technologies and Information Team Manager

Elizabeth Neuendorf

Senior Research Associate

Carol Cesar

European Key Account Manager

员工

Colette Cote

Chief Portfolio Officer and General Manager, US Operations

Chrystelle Stirnemann

Responsable Assurance Qualité - Pharmacien Responsable Intérimaire

Yoann Lecat

Responsable Ressources Humaines

Tristan Poisson

Analyste comptable et financier

外贸获客 查找关键决策人

10亿+海关交易数据,1.2亿企业数据,2亿+企业联系人数据,1000千万真实采购商。覆盖200+个国家及地区,95%外贸重点拓展市场,可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少,成就更大,销售更聪明

查找更多 B2B 联系人,丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google